Latest filing published 04 Nov 2026 for Arcutis Biotherapeutics, Inc., €1.2M.
Insider track record
Masaru Matsuda: trading record in brief
Masaru Matsuda is a declared insider of Arcutis Biotherapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 8 September 2026 and the latest from 4 November 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 4 November 2026 came the latest disclosure, a transaction for €1.2M in Arcutis Biotherapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Masaru Matsuda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ US$34.3168CommonSEC144:0001628280-26-070283
- 1,219 shares@ US$31.86340.0010% mcap10.6% of flowCommonSEC144:0001628280-26-068986
- 13,663 shares@ US$25.02620.0082% mcap100.0% of flowCommonSEC144:0001628280-26-060930
3 of 3 declarations
